The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical appraisal." They have so much to teach me.

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Novavax (NasdaqGS:NVAX) recently reported initial results from its Phase 3 trial for its COVID-19-Influenza Combination and seasonal influenza vaccines, which showed immune responses comparable to ...

NVAX Stock: Recent Developments The above announcement came just under a month after it received the long-awaited FDA approval for Nuvaxovid, albeit with a narrower label than initially expected ...

As most readers may be aware (and as I covered in my last note), Novavax, with the help of $1.6bn funding from the U.S. government in 2020, created a COVID vaccine, Nuvaxovid, which was as ...